analyst
GO
NASDAQ · GOSS
Gossamer Bio, Inc.
Healthcare · Biotechnology
$10.38
Down-$0.08 (-0.72%)
Updated Sep 16, 2026, 1:59 PM
SID Score
6.5/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 824.25M
- P/E ratio
- -5.95
- Dividend yield
- 0.00%
- 52-week range
- $0.11 – $14.75
- Volume
- 220.5K
- Avg. volume
- 3.24M
Price performance
GOSS price history
1M range · 20 trading sessions · Daily adjusted prices
GOSS closed at $10.38 after 20 trading sessions, up 7153.67% for the selected period.
- Last close
- $10.38
- Period change
- +7153.67%
- Period low
- $0.14
- Period high
- $14.39
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 15, 2026 | $10.61 | $10.97 | $10.12 | $10.38 | 220.5K |
| Sep 14, 2026 | $10.95 | $11.0782 | $10.07 | $10.70 | 325.91K |
| Sep 11, 2026 | $12.48 | $12.52 | $10.47 | $10.73 | 474.15K |
| Sep 10, 2026 | $12.216 | $12.536 | $11.216 | $11.392 | 165.33K |
| Sep 9, 2026 | $12.00 | $13.784 | $11.992 | $12.776 | 296.18K |
| Sep 8, 2026 | $13.72 | $14.752 | $13.464 | $14.392 | 86.49K |
| Sep 4, 2026 | $0.1715 | $0.1807 | $0.168 | $0.1753 | 8.09M |
| Sep 3, 2026 | $0.173 | $0.176 | $0.1635 | $0.1756 | 5.73M |
| Sep 2, 2026 | $0.1656 | $0.1732 | $0.1614 | $0.1727 | 5.76M |
| Sep 1, 2026 | $0.1652 | $0.1729 | $0.16 | $0.1674 | 7.32M |
| Aug 31, 2026 | $0.171 | $0.1801 | $0.168 | $0.17 | 10.15M |
| Aug 28, 2026 | $0.172 | $0.1733 | $0.164 | $0.1701 | 7.92M |
| Aug 27, 2026 | $0.1761 | $0.1779 | $0.163 | $0.1701 | 15.45M |
| Aug 26, 2026 | $0.1991 | $0.2019 | $0.17 | $0.1739 | 29.15M |
| Aug 25, 2026 | $0.1796 | $0.2137 | $0.1681 | $0.2045 | 47.56M |
| Aug 24, 2026 | $0.15 | $0.1872 | $0.1457 | $0.175 | 47.11M |
| Aug 21, 2026 | $0.1695 | $0.1695 | $0.145 | $0.1547 | 131.36M |
| Aug 20, 2026 | $0.1581 | $0.1639 | $0.1505 | $0.1575 | 6.73M |
| Aug 19, 2026 | $0.1497 | $0.1585 | $0.142 | $0.1566 | 6.91M |
| Aug 18, 2026 | $0.14 | $0.1479 | $0.1382 | $0.1431 | 6.79M |
Latest GOSS news
The latest Smart Investors Daily articles mentioning GOSS.
Stock researchCompany · Financials
Loading stock research…

